Published in Rev Esp Quimioter on December 01, 2004
Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis (1999) 2.81
Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother (1987) 2.31
[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease]. Arch Bronconeumol (2002) 2.03
Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect (1997) 1.64
Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis (1995) 1.64
Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms. J Antimicrob Chemother (1986) 1.46
[Human papillomavirus vaccines: a new challenge for pediatricians]. An Pediatr (Barc) (2006) 1.40
[The return of gram-positive bacteria]. Enferm Infecc Microbiol Clin (1993) 1.38
[Comparative study of pneumococcal bacteremia in patients with and without HIV infection]. Rev Clin Esp (1993) 1.36
Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother (2003) 1.34
[Use of antibiotics in exacerbated chronic obstructive pulmonary disease]. Aten Primaria (2001) 1.31
Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein. J Biol Chem (1998) 1.30
Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci. Antimicrob Agents Chemother (2000) 1.28
Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother (1994) 1.27
Specificities of antibodies to native DNA. Scand J Rheumatol Suppl (1975) 1.24
The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis (2000) 1.17
Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents. Antimicrob Agents Chemother (1999) 1.12
Comparison of epidemiological markers of Salmonella strains isolated from different sources in Spain. J Clin Microbiol (1992) 1.10
Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999. J Antimicrob Chemother (2001) 1.10
Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother (1993) 1.06
A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects. Rev Esp Quimioter (2010) 0.99
Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989. Eur J Clin Microbiol Infect Dis (1992) 0.97
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Clin Microbiol Infect (2011) 0.96
Transcriptional attenuation control of the tylosin-resistance gene tlrA in Streptomyces fradiae. Mol Microbiol (1994) 0.96
Endophthalmitis caused by Listeria monocytogenes. J Clin Microbiol (2001) 0.95
In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance. Antimicrob Agents Chemother (2004) 0.95
In vitro activity of tigecycline against Bacteroides species. J Antimicrob Chemother (2005) 0.93
[Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain]. An Esp Pediatr (2002) 0.92
Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol (1994) 0.91
Impact of the BACTEC NR system in detecting Candida fungemia. J Clin Microbiol (1990) 0.91
Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1992) 0.91
Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents. Antimicrob Agents Chemother (1990) 0.89
[Immunization schedule of the Spanish Association of Pediatrics: recommendations 2008]. An Pediatr (Barc) (2008) 0.88
Antibiotic inactivating enzymes from a clinical isolate of Agrobacterium radiobacter. J Antimicrob Chemother (1989) 0.88
In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates. Rev Esp Quimioter (2011) 0.88
Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study. Diagn Microbiol Infect Dis (1999) 0.86
[Bacteremia by Staphylococcus aureus: analysis of 311 episodes]. Enferm Infecc Microbiol Clin (1999) 0.85
Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the toxic oil syndrome. J Autoimmun (1995) 0.84
Distribution of mef(A) and erm(B) genes in macrolide-resistant blood isolates of viridans group streptococci. J Antimicrob Chemother (2001) 0.83
Tuberculous meningitis. Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection. Arch Neurol (1996) 0.83
Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci. J Antimicrob Chemother (2001) 0.83
Peritonitis caused by Haemophilus parainfluenzae in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol (1999) 0.81
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents. J Antimicrob Chemother (1999) 0.81
[1st Spanish epidemic of plasmid resistance to 3d generation cephalosporins: the implication of SHV-2]. Enferm Infecc Microbiol Clin (1992) 0.81
Activity of doripenem against extended-spectrum beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates. Eur J Clin Microbiol Infect Dis (2010) 0.80
[Community-acquired respiratory infections]. Enferm Infecc Microbiol Clin (1997) 0.80
Penicillin tolerance of group A streptococci. Eur J Clin Microbiol Infect Dis (1989) 0.80
Prevalence of herpesvirus DNA in MS patients and healthy blood donors. Acta Neurol Scand (2002) 0.79
A rare cause of pericarditis. Clin Microbiol Infect (2003) 0.79
[Detection of viral genomes of the Herpesviridae family in multiple sclerosis patients by means of the polymerase chain reaction (PCR)]. Enferm Infecc Microbiol Clin (2000) 0.79
[Vaccination schedule of the Spanish Association of Pediatrics: recommendations 2007]. An Pediatr (Barc) (2007) 0.79
[Sensitivity to antimicrobials of group A Streptococcus]. Enferm Infecc Microbiol Clin (1989) 0.79
DNA release and appearance of antinuclear antibodies in chronic hemodialysis patients. Nephron (1982) 0.78
[Diarrhea associated with Helicobacter pullorum in a child]. Rev Esp Quimioter (2011) 0.78
[Prevalence and treatment of Gram-positive infections in internal medicine departments of Spanish hospitals: IGP Study]. Rev Esp Quimioter (2003) 0.78
In vitro activity of tigecycline against ampicillin-resistant Haemophilus influenzae isolates. J Antimicrob Chemother (2005) 0.77
[Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood]. Rev Esp Quimioter (1999) 0.77
[Second consensus statement on the use of antimicrobial drugs in chronic obstructive pulmonary disease exacerbations]. Rev Esp Quimioter (2002) 0.77
[Bacteremic infection due to Nocardia otitidiscaviarum: case report and review]. An Med Interna (2005) 0.77
In vitro activity of ceftobiprole and seven other antimicrobial agents against invasive Streptococcus pneumoniae isolates in Spain. Eur J Clin Microbiol Infect Dis (2011) 0.77
Outbreak of TEM-24-producing Enterobacter aerogenes in a Spanish hospital. Microb Drug Resist (2003) 0.77
[National consensus on acute otitis media (OMA)]. An Pediatr (Barc) (2007) 0.76
Influence of gene dosing on antibiotic resistance mediated by inactivating enzymes. J Chemother (1989) 0.75
In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains. Antimicrob Agents Chemother (2001) 0.75
Hepatitis G virus infection in Spanish patients with hepatocellular carcinoma. Liver (1998) 0.75
[Evaluation of an agglutination method of latex particles sensitized for the detection of vaginal candidiasis]. Med Clin (Barc) (1990) 0.75
[Invasive pulmonary aspergillosis in non-neutropenic patients]. Rev Esp Quimioter (2016) 0.75
[In vitro activities of colistin combinations against Pseudomonas aeruginosa isolated from the intensive care unit]. Rev Esp Quimioter (2008) 0.75
[Vancomycin-resistant enterococci: in vitro activity of quinupristin / dalfoprostin (RP 59500)]. Enferm Infecc Microbiol Clin (1999) 0.75
[Beta-lactamase producing bacteria in the pharyngeal flora of patients with acute pharyngitis]. Enferm Infecc Microbiol Clin (1995) 0.75
[Bacteremic pneumonia caused by Rhodococcus equi and HIV infection. Report of a new case and review of the literature]. Enferm Infecc Microbiol Clin (1991) 0.75
[Post-pill amenorrhea and anovulation (author's transl)]. Reproduccion (1977) 0.75
[Carrier state of groups A, B, C, and D beta-hemolytic streptococci]. Enferm Infecc Microbiol Clin (1994) 0.75
[National consensus on acute otitis media]. Acta Otorrinolaringol Esp (2007) 0.75
Evaluation of four methods for the detection of streptococcal group A antigen directly from throat swabs. Microbiologia (1988) 0.75
[Criteria for including vaccines in the immunization schedule of the Spanish Association of Pediatrics]. An Pediatr (Barc) (2008) 0.75
[Consensus document on pneumococcal vaccination in adults at risk by age and underlying clinical conditions. 2017 Update]. Rev Esp Quimioter (2017) 0.75
[Sternal osteomyelitis and mediastinitis due to Fusobacterium necrophorum]. Rev Esp Quimioter (2014) 0.75
[Detection of human papillomavirus DNA in women with and without signs of infection]. Enferm Infecc Microbiol Clin (1991) 0.75
[Bacteremia caused by Streptococcus pneumoniae and HIV infection]. Enferm Infecc Microbiol Clin (1991) 0.75
[Antinuclear antibodies]. Sangre (Barc) (1977) 0.75
[Microbial drug resistance and the presence of plasmids in Salmonella strains isolated from different sources]. Enferm Infecc Microbiol Clin (1994) 0.75
[Methicillin-resistant Staphylococcus aureus: role of the microbiologist]. Enferm Infecc Microbiol Clin (1992) 0.75
In vitro selections of resistant strains by quinolones. J Chemother (1989) 0.75
[Vaccination schedule of the Spanish association of pediatrics: recommendations 2009]. An Pediatr (Barc) (2008) 0.75
[The future development of vaccines]. Rev Esp Quimioter (2007) 0.75
[Why are pediatric empyemas on the increase in Spain?]. An Pediatr (Barc) (2008) 0.75
[Patterns of susceptibility in group A streptococci]. Enferm Infecc Microbiol Clin (1994) 0.75
[How to stimulate ovulation?]. Tokoginecol Pract (1977) 0.75